NANCY SMITH: Open Payments
NPI 1639452121 · GEORGETOWN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 25 payments from 10 companies in 2025. Trend: 2023 $652 · 2024 $568 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $121 |
| Dexcom, Inc. | 1 | $95 |
| ABBVIE INC. | 4 | $79 |
| PFIZER INC. | 3 | $64 |
| Exact Sciences Corporation | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: DEXCOM G7 GSS (161), UBRELVY, The Cologuard Plus Collection Kit, PREVNAR 20, Wegovy, Ozempic, ZORYVE, VOQUEZNA.
Industry payments across DE — which companies pay providers there.
